Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1949 1
1959 1
1961 1
1964 1
1965 1
1969 1
1971 1
1972 1
1974 2
1976 2
1977 9
1978 16
1979 29
1980 33
1981 62
1982 45
1983 45
1984 41
1985 36
1986 33
1987 25
1988 25
1989 19
1990 32
1991 28
1992 21
1993 34
1994 37
1995 53
1996 60
1997 47
1998 50
1999 57
2000 76
2001 74
2002 59
2003 77
2004 70
2005 87
2006 103
2007 94
2008 99
2009 90
2010 119
2011 139
2012 151
2013 201
2014 219
2015 276
2016 259
2017 269
2018 257
2019 279
2020 212
2021 210
2022 184
2023 158
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

4,292 results

Results by year

Filters applied: . Clear all
Page 1
Next-Generation Whole-Cell Pneumococcal Vaccine.
Morais V, Texeira E, Suarez N. Morais V, et al. Vaccines (Basel). 2019 Oct 16;7(4):151. doi: 10.3390/vaccines7040151. Vaccines (Basel). 2019. PMID: 31623286 Free PMC article. Review.
Although Pneumococcal Conjugate Vaccines (PCVs) are available and have significantly reduced the rate of invasive pneumococcal diseases, there is still a need for new vaccines with unlimited serotype coverage, long-lasting protection, and lower cost to be developed. One of the mo …
Although Pneumococcal Conjugate Vaccines (PCVs) are available and have significantly reduced the rate of invasive pneumococcal diseases, the …
Pneumococcal Vaccine Recommendations for Old-Age Home Indian Residents: A Literature Review.
Ghia CJ, Rambhad G. Ghia CJ, et al. Gerontol Geriatr Med. 2022 Sep 1;8:23337214221118237. doi: 10.1177/23337214221118237. eCollection 2022 Jan-Dec. Gerontol Geriatr Med. 2022. PMID: 36081416 Free PMC article. Review.
We performed an extensive review of Indian literature (indexed and non-indexed publications) from 2010 to 2020 using search strings "Pneumococcal vaccine AND Recommendations AND India," "Pneumococcal vaccine AND Guidelines AND India," followed by a han …
We performed an extensive review of Indian literature (indexed and non-indexed publications) from 2010 to 2020 using search strings "Pneu …
Pneumococcal Vaccine Recommendation.
Kuehn B. Kuehn B. JAMA. 2020 Jan 14;323(2):112. doi: 10.1001/jama.2019.20494. JAMA. 2020. PMID: 31935035 No abstract available.
20-Valent Pneumococcal Conjugate Vaccine in Older People.
Sewell HE, Conway S, Douglas C. Sewell HE, et al. Sr Care Pharm. 2023 Apr 1;38(4):148-155. doi: 10.4140/TCP.n.2023.148. Sr Care Pharm. 2023. PMID: 36949560 Review.
Study Selection/Data Extraction Nine articles on 20-valent Pneumococcal vaccine were identified based on the above search terms. ...PCV20 was well-tolerated with adverse events similar to earlier Pneumococcal vaccine formulations. Conclusion The simpli …
Study Selection/Data Extraction Nine articles on 20-valent Pneumococcal vaccine were identified based on the above search term …
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Chichili GR, Smulders R, Santos V, Cywin B, Kovanda L, Van Sant C, Malinoski F, Sebastian S, Siber G, Malley R. Chichili GR, et al. Vaccine. 2022 Jul 29;40(31):4190-4198. doi: 10.1016/j.vaccine.2022.05.079. Epub 2022 Jun 9. Vaccine. 2022. PMID: 35690500 Free article. Clinical Trial.
This phase 1/2 study evaluated safety/tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine (ASP3772) based on high-affinity complexing of proteins and polysaccharides. METHODS: Pneumococcal vaccine-naive adults aged 18-85 years wer …
This phase 1/2 study evaluated safety/tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine (ASP3772) base …
Pneumococcal vaccine.
White RT. White RT. Thorax. 1988 May;43(5):345-8. doi: 10.1136/thx.43.5.345. Thorax. 1988. PMID: 3057673 Free PMC article. Review. No abstract available.
Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis.
Wannarong T, Ekpatanaparnich P, Boonyasiri A, Supapueng O, Vathanophas V, Tanphaichitr A, Ungkanont K. Wannarong T, et al. Otolaryngol Head Neck Surg. 2023 Oct;169(4):765-779. doi: 10.1002/ohn.327. Epub 2023 Mar 16. Otolaryngol Head Neck Surg. 2023. PMID: 36924215 Review.
OBJECTIVE: To assess the effect of the pneumococcal vaccine (PCV) toward the surgical management and complications of otitis media. ...
OBJECTIVE: To assess the effect of the pneumococcal vaccine (PCV) toward the surgical management and complications of otitis m …
Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review.
Nasreen S, Gebretekle GB, Lynch M, Kurdina A, Thomas M, Fadel S, Houle SKD, Waite NM, Crowcroft NS, Allin S. Nasreen S, et al. Vaccine. 2022 Jul 30;40(32):4380-4393. doi: 10.1016/j.vaccine.2022.06.056. Epub 2022 Jun 30. Vaccine. 2022. PMID: 35781171 Review.
OBJECTIVES: We sought to understand the current landscape of published literature on the predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries, and to identify the gaps in literature to inform future research. ... …
OBJECTIVES: We sought to understand the current landscape of published literature on the predictors of pneumococcal vaccine up …
Pneumococcal vaccine for asthma.
Sheikh A, Alves B, Dhami S. Sheikh A, et al. Cochrane Database Syst Rev. 2001;2002(3):CD002165. doi: 10.1002/14651858.CD002165. Cochrane Database Syst Rev. 2001. PMID: 11687018 Free PMC article. Updated. Review.
OBJECTIVES: To determine the efficacy of pneumococcal vaccine in reducing mortality or morbidity from pneumococcal disease in asthmatics. ...SELECTION CRITERIA: Randomised controlled trials, with or without blinding, in which pneumococcal vaccine has b …
OBJECTIVES: To determine the efficacy of pneumococcal vaccine in reducing mortality or morbidity from pneumococcal disease in …
Pneumococcal vaccine for asthma.
Sheikh A, Alves B, Dhami S. Sheikh A, et al. Cochrane Database Syst Rev. 2002;(1):CD002165. doi: 10.1002/14651858.CD002165. Cochrane Database Syst Rev. 2002. PMID: 11869626 Review.
OBJECTIVES: To determine the efficacy of pneumococcal vaccine in reducing mortality or morbidity from pneumococcal disease in asthmatics. ...SELECTION CRITERIA: Randomised controlled trials, with or without blinding, in which pneumococcal vaccine has b …
OBJECTIVES: To determine the efficacy of pneumococcal vaccine in reducing mortality or morbidity from pneumococcal disease in …
4,292 results